Brand name: Calcitriol (AN)
Calcitriol (AN) is a medicine containing the active ingredient(s) calcitriol. On this page you will find out more about Calcitriol (AN), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: calcitriol
Information for medicine and pack size:
Calcitriol (AN) 0.25 microgram soft capsule, 100
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Calcitriol AN is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. Calcitriol AN is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. Calcitriol AN is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance |
Red coloured, oval soft gelatin capsules containing a clear oily liquid.
Images are the copyright of the Pharmacy Guild of Australia |
| Dosage Form | Capsule, soft |
| Route of administration | Oral |
| Medicine schedule |
100 Capsules: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Blister Pack |
|---|---|
| Storage temperature | Store below 25 degrees Celsius |
| Storage conditions | Protect from Light |
| Life time | 3 Years |
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
Found 15 results
Calcitriol AN Capsules - myDr.com.au
Calcitriol AN Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Calcitriol Capsules - myDr.com.au
APO-Calcitriol Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Calcitriol-GA Capsules - myDr.com.au
Calcitriol-GA Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Calcijex | myVMC
Calctriol is used in treatment of low calcium levels (hypocalcaemia) in patients on chronic renal dialysis
Read more on myVMC – Virtual Medical Centre website
Inherited Vitamin D Disorders | myVMC
Inherited vitamin D disorders prevent the kidneys processing vitamin D and cause rickets, a skeletal condition affecting the bones of the skull and legs.
Read more on myVMC – Virtual Medical Centre website
Kosteo Capsules - myDr.com.au
Kosteo Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Rocaltrol Capsules - myDr.com.au
Rocaltrol Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Renal Bone disease (Renal Osteodystrophy) | myVMC
Renal Bone Disease or Renal osteodystrophy is a bone complication of chronic kidney failure or kidney disease. It causes weak bones which fracture.
Read more on myVMC – Virtual Medical Centre website
Treatment of Psoriasis | myVMC
Psoriasis is a disease which affects multiple systems within the body, predominantly the skin and the joints. Skin disease which can present in multiple different ways and degrees of severity is the hallmark of psoriasis. The severity of psoriasis is defined in terms of which body parts and how much body surface area are involved.
Read more on myVMC – Virtual Medical Centre website
How your skin is changed in menopause information | myVMC
Menopause is a time of significant changes to skin. While skin is linked with beauty, it is not all about looks - it has many important effects on health.
Read more on myVMC – Virtual Medical Centre website
Found 3 results
Vitamin D supplementation for prevention of mortality in adults | Cochrane
To assess the beneficial and harmful effects of vitamin D for prevention of mortality in healthy adults and adults in a stable phase of disease.
Read more on Cochrane (Australasian Centre) website
Vitamin D compounds for people with chronic kidney disease requiring dialysis | Cochrane
People with reduced kidney function (chronic kidney disease; CKD) develop changes in circulating blood levels of calcium and phosphorus. The kidney gradually loses the ability to remove phosphorus from the blood and cannot activate adequate amounts of vitamin D, to maintain normal levels of calcium. The parathyroid gland senses these changes and compensates to increase calcium by elevating production and release of parathyroid hormone. These metabolic changes alter bone metabolism to release calcium and accordingly lead to bone abnormalities including altered bone production. Consequently bone deformation, bone pain, and altered risks of fracture may occur.
Read more on Cochrane (Australasian Centre) website
Vitamin D compounds for people with chronic kidney disease not requiring dialysis | Cochrane
People with lower kidney function (chronic kidney disease; CKD) develop changes in circulating blood levels of calcium and phosphorus. The kidney gradually loses the ability to remove phosphorus from the blood and cannot activate adequate amounts of vitamin D to maintain normal levels of calcium. The parathyroid gland senses these changes and compensates to increase calcium by elevating production and release of parathyroid hormone (PTH). These metabolic changes alter bone metabolism to release calcium and accordingly lead to bone abnormalities including altered bone production. In turn, bony changes may result in bone deformation, bone pain, and altered risks of fracture.
Read more on Cochrane (Australasian Centre) website
